Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

Liarozole claimed for inhibiting calcitriol metabolism

Sep. 13, 1996

Retinoid compounds for dermatological disorders

Sep. 13, 1996

Allergen describes compounds with retinoid-like activity

Sep. 6, 1996

Interferon gamma-1b enters pivotal trials for atopic dermatitis

Sep. 6, 1996

ProCyte cleared for clinical trials with wound-healing product

Sep. 6, 1996

ProCyte issued patents covering hair loss applications

Sep. 6, 1996

Ornithine decarboxylase inhibitors for dermatology

Sep. 6, 1996

Xoma/Genentech to commence clinical trials with humanized monoclonal antibody

Sep. 6, 1996

ADCON-L and ADCON-T/N research demonstrates efficacy

Aug. 30, 1996

Treatment for keratinization disorders described by Janssen

Aug. 30, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.